Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Total Liabilities
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. total liabilities. Based on the latest financial reports, Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) has total liabilities worth CN¥717.55 Million CNY (≈ $105.00 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 605016 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2025)
Total liabilities of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2025. This chart illustrates how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shenzhen Zhenye Group Co Ltd
SHE:000006
|
China | CN¥11.09 Billion |
|
United Corporations Limited
TO:UNC
|
Canada | CA$154.84 Million |
|
Zotye Automobile Co Ltd
SHE:000980
|
China | CN¥3.19 Billion |
|
UroGen Pharma Ltd
NASDAQ:URGN
|
USA | $384.99 Million |
|
Forestar Group Inc
NYSE:FOR
|
USA | $1.35 Billion |
|
PagSeguro Digital Ltd
NYSE:PAGS
|
USA | $59.92 Billion |
|
Universal Insurance Holdings Inc
NYSE:UVE
|
USA | $2.67 Billion |
|
Sonic Automotive Inc
NYSE:SAH
|
USA | $5.14 Billion |
Liability Composition Analysis (2016–2025)
This chart breaks down Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 605016 total assets.
Liquidity & Leverage Metrics
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Total Liabilities Ratios Explained
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.51 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.34 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2025)
The table below shows the annual total liabilities of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥475.19 Million ≈ $69.54 Million |
+42.16% |
| 2024-12-31 | CN¥334.27 Million ≈ $48.91 Million |
+35.69% |
| 2023-12-31 | CN¥246.35 Million ≈ $36.05 Million |
+93.99% |
| 2022-12-31 | CN¥126.99 Million ≈ $18.58 Million |
+60.65% |
| 2021-12-31 | CN¥79.05 Million ≈ $11.57 Million |
-45.45% |
| 2020-12-31 | CN¥144.91 Million ≈ $21.20 Million |
-7.87% |
| 2019-12-31 | CN¥157.28 Million ≈ $23.01 Million |
+45.50% |
| 2018-12-31 | CN¥108.09 Million ≈ $15.82 Million |
-42.92% |
| 2017-12-31 | CN¥189.38 Million ≈ $27.71 Million |
-29.64% |
| 2016-12-31 | CN¥269.14 Million ≈ $39.38 Million |
-- |
About Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of food and feed additives in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto-oligosaccharide, galacto-oligosaccharide, and xylo-oligosaccharide. It also provides starch sugars comprising allulose, maltit… Read more